Skip to Main Content

Paper Details

The Case for Expanding the FDA Box Warning on Clopidogrel to CYP2C19 Intermediate Metabolizers.
Clin Pharmacol Ther
3
2021
Author NameAffiliation
Dan M RodenVanderbilt University Medical Center
Dan M RodenVanderbilt University Medical Center
Dan M RodenVanderbilt University Medical Center
Josh F PetersonVanderbilt University Medical Center
Josh F PetersonVanderbilt University Medical Center
  • 1 - 5

Datasets

Release 1.2